₹43,356.55
(-103.29)(-0.23%)
01 Jul , 2025 | 04:14 PM
Open
₹43,597.5
Prev. Close
₹43,459.85
Market Cap.
₹0
Div Yield
0
PE
0
PB
0
₹43,050.85
₹43,604.7
Performance
One Week (%)
4.08
One Month (%)
5.38
One Year (%)
20.85
YTD (%)
8.49
Company Name | CMP | High | Low | Volume |
---|---|---|---|---|
Abbott India Ltd | 34,665 | 35,800 | 34,455 | 15,146 |
Glaxosmithkline Pharmaceuticals Ltd | 3,353.3 | 3,450 | 3,345.1 | 1,22,742 |
J B Chemicals & Pharmaceuticals Ltd | 1,645.6 | 1,690 | 1,626 | 8,02,570 |
Pfizer Ltd | 5,698.5 | 5,765 | 5,688 | 44,544 |
Lupin Ltd | 1,960.9 | 1,970 | 1,905 | 10,92,022 |
Ipca Laboratories Ltd | 1,371.9 | 1,389.1 | 1,355.1 | 1,93,130 |
Neuland Laboratories Ltd | 11,878 | 12,051 | 11,820 | 17,164 |
Aurobindo Pharma Ltd | 1,132.5 | 1,138.5 | 1,112 | 9,61,883 |
Natco Pharma Ltd | 933 | 941 | 917.6 | 14,56,642 |
Granules India Ltd | 489.15 | 498.05 | 483.35 | 7,37,015 |
Ajanta Pharma Ltd | 2,502.7 | 2,605 | 2,494 | 2,22,786 |
Poly Medicure Ltd | 2,269.2 | 2,274 | 2,205 | 1,21,042 |
Gland Pharma Ltd | 1,878 | 1,884.8 | 1,822.4 | 4,17,127 |
Biocon Ltd | 362.5 | 363.45 | 354 | 52,93,503 |
Alkem Laboratories Ltd | 4,849 | 4,945 | 4,820 | 2,20,023 |
Glenmark Pharmaceuticals Ltd | 1,754.3 | 1,764 | 1,740.1 | 4,47,785 |
Max Healthcare Institute Ltd | 1,279.7 | 1,307.9 | 1,271.6 | 20,67,169 |
Fortis Healthcare Ltd | 774.75 | 794 | 773 | 17,43,062 |
Syngene International Ltd | 636.6 | 643.7 | 633.3 | 4,15,274 |
Global Health Ltd | 1,151.4 | 1,155.7 | 1,137 | 1,94,407 |
Krishna Institute of Medical Sciences Ltd | 686.25 | 689.9 | 660.9 | 8,72,523 |
Rainbow Childrens Medicare Ltd | 1,572.4 | 1,590 | 1,525.2 | 2,13,326 |
Mankind Pharma Ltd | 2,287 | 2,348 | 2,258 | 16,15,351 |
Alembic Pharmaceuticals Ltd | 1,012.1 | 1,051.7 | 1,001.7 | 8,58,973 |
Dr Lal Pathlabs Ltd | 2,774 | 2,818.8 | 2,760.8 | 2,90,592 |
Narayana Hrudayalaya Ltd | 2,094 | 2,201.3 | 2,076.2 | 7,66,832 |
Laurus Labs Ltd | 746.05 | 750 | 721.05 | 47,04,542 |
Aster DM Healthcare Ltd | 589.7 | 599 | 586 | 3,50,282 |
Cohance Lifesciences Ltd | 960.3 | 972 | 936 | 3,45,784 |
Piramal Pharma Ltd | 204.73 | 205.5 | 201.12 | 27,48,819 |
The ₹15.84 crore order, inclusive of taxes, will be executed entirely within India and is scheduled for completion by November 2, 2025
1 Jul 2025|02:03 PM
Apollo Hospital, Bharat Elec hits 52-week high in Nifty.
1 Jul 2025|01:54 PM
The total Gross Development Value (GDV) is estimated at ₹4,521 crore, making this one of the most extensive urban renewal projects in the city.
1 Jul 2025|12:54 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.